DLA Piper has advised Active Ownership Capital as anchor shareholder of Formycon on the deal. honert, Norton Rose Fulbright, Baumann Inderkum & Muheim and Ashurst advised…
Formycon’s Acquisition of the Biosimilar Candidates FYB201 and FYB202

DLA Piper has advised Active Ownership Capital as anchor shareholder of Formycon on the deal. honert, Norton Rose Fulbright, Baumann Inderkum & Muheim and Ashurst advised…
You must be a Standard 1 Year member to access this content.
…
You must be a Standard 1 Year member to access this content.